Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01020760
Other study ID # Version 1
Secondary ID
Status Completed
Phase N/A
First received November 25, 2009
Last updated April 25, 2012
Start date September 2008
Est. completion date October 2010

Study information

Verified date April 2012
Source NHS Greater Glasgow and Clyde
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the effect of postoperative posturing on the outcome of macular hole surgery. Current practice is divided; some individuals are advised to posture face-down for 10 days and others are advised that posturing is unnecessary. By evaluating the effect of posturing in a prospective randomised controlled trial the investigators hope to determine best practice, enabling surgeons and patients to make informed decisions regarding postoperative management.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date October 2010
Est. primary completion date August 2010
Accepts healthy volunteers No
Gender Both
Age group 16 Years and older
Eligibility Inclusion Criteria:

1. Patients having surgery for idiopathic full thickness macular hole

2. Able and willing to posture face-down for 10 days postoperatively

3. Agree to participate in the trial and able to give informed consent

Exclusion Criteria:

1. History of visual loss suggesting a duration of macular hole greater than 12 months

2. Patients unable or unwilling to posture face-down for 10 days postoperatively

3. History of trauma that may have been causative

4. Age less than 16 years (in practice idiopathic macular hole is extremely rare in patients under 30 years).

5. Previous vitrectomy surgery

6. Additional retinal breaks occurring during surgery that necessitate post-operative posturing to prevent retinal detachment.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Face down posture
Patients are requested to maintain a strict face down posture for 50 minutes out of every hour for seven days after surgery.

Locations

Country Name City State
United Kingdom Gartnavel General Hospital Glasgow

Sponsors (1)

Lead Sponsor Collaborator
NHS Greater Glasgow and Clyde

Country where clinical trial is conducted

United Kingdom, 

References & Publications (1)

Yorston D, Siddiqui MA, Awan MA, Walker S, Bunce C, Bainbridge JW. Pilot randomised controlled trial of face-down posturing following phacovitrectomy for macular hole. Eye (Lond). 2012 Feb;26(2):267-71. doi: 10.1038/eye.2011.220. Epub 2011 Sep 23. Erratum — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary estimate variance and effect size order to inform power calculations for further studies. one year No
Secondary visual acuity and complications one year No
Secondary estimate recruitment rate and establish protocol/procedure one year No
See also
  Status Clinical Trial Phase
Completed NCT03332758 - Inflammasomes in Cell Death in FTMH, ERM, and RRD
Recruiting NCT04498624 - Inverted Flap Versus Internal Limiting Membrane Peeling in Small Full Thickness Macular Holes N/A
Completed NCT05897671 - Foveal Sparing ILM Peeling With ILM Flap Transposition
Completed NCT01226160 - Pilot Randomised Controlled Trial of Posturing Following Surgery for Full-thickness Macular Hole Phase 0
Recruiting NCT05828251 - Full Thickness Macular Hole; Should it be Handled Subacutely? N/A